本レポートは、世界のヘルスケアCMO市場をCovid-19の影響や市場規模などを詳細に分析しています。分析内容は、金額ベースの市場規模、セグメント別の市場シェアなどです。また、包括的なセグメント分析を行い、その過去と予測値を掲載しています。
さらに、市場における主要な機会を評価し、業界の成長を促進している要因と今後の要因についても概説しています。また、これまでの成長パターン、成長ドライバー、現在および将来のトレンドを考慮し、2021年から2025年までのヘルスケアCMO市場全体の成長を予測しています。
ヘルスケアCMO市場は非常に細分化されており、本レポートでは、Catalent Pharma Solution、Recipharm、Aurobindo Pharma Ltd.、Boehringher Ingelheimなど、ヘルスケアCMO業界の主要企業の企業情報を掲載しています。このセグメントでは、各企業の事業概要、財務概要、採用したビジネス戦略などを紹介しています。
製薬会社が第三者（製造受託機関）に依頼して、自社製品の部品や製品全体を製造するアウトソーシングを製造受託といいます。製造受託機関（CMO）は、別企業のブランド名で製品の製造を請け負います。
ヘルスケアCMOは、医薬品CMOと医療機器CMOに分けられます。医薬品CMOは、新薬の化学式が発見された後、それを製品として製造し、製薬会社が自社のブランド名で市場に販売できるようにする仕事をしています。医薬品CMOが提供するサービスは、大きく分けて、一次製造（原薬製造）と二次製造（製剤製造）の2つがあります。医療機器の受託製造は、企業が新しい機器を市場に投入する競争の中で、医療機器産業の中でも最も急速に成長している分野の一つです。
世界の医療用CMO市場は、COVID-19の普及後、漸進的な成長を記録しており、今後も同様の傾向を辿ることが予想されます。この成長の主な要因は、高齢者人口の急増、医療費の増加、慢性疾患の増加、ジェネリック医薬品の需要の高まりです。一方で、技術の急速な進歩や、特許・著作権・商標・企業秘密への依存など、ヘルスケアCMO業界が直面する課題もあります。
目次
1. Executive Summary
2. Introduction
2.1 Contract Manufacturing: An Overview
2.1.1 Healthcare CMOs
2.1.2 Healthcare CMOs Market Segments
2.1.3 Pharmaceutical CMOs
Active Pharmaceutical Ingredients (API)
Finished Dosage Formulations (FDF)
2.1.4 Medical CMOs
2.2 Pharmaceutical Outsourcing: An Overview
2.2.1 Pharmaceutical Outsourcing Market Segments
2.3 Pharmaceutical CMOs v/s CDMOs
3. Global Market Analysis
3.1 Global Healthcare CMO Market Analysis
3.1.1 Global Healthcare CMO Market by Value
3.1.2 Global Healthcare CMO Market by Segments (pharmaceutical and medical device)
3.2 Global Healthcare CMO Market: Segment Analysis
3.2.1 Global Medical Device CMO Market by Value
3.2.2 Global Pharmaceutical CMO Market by Value
3.3 Global Pharmaceutical CMO Market Analysis
3.3.1 Global Pharmaceutical CMO Market by Segments (active pharmaceutical ingredients (API) and others (finished dosage formulation (solid dosage forms and injectable) and packaging))
3.4 Global Pharmaceutical CMO Market: Segment Analysis
3.4.1 Global Active Pharmaceutical Ingredient CMO Market by Value
3.4.2 Global Others Pharmaceutical CMO Market by Value
3.5 Global Healthcare CMO Market Regional Analysis
3.5.1 Global Healthcare CMO Market by Region (Asia Pacific and ROW)
3.6 Global Pharmaceutical CDMO Market: An Analysis
3.6.1 Global Pharmaceutical CDMO Market by Value
3.6.2 Global Pharmaceutical CDMO Market by Region (the US, Europe, India, China and others)
4. CMO Regional Analysis
4.1 Asia Pacific Healthcare CMO Market Analysis
4.1.1 Asia Pacific Healthcare CMO Market by Value
4.2 ROW Healthcare CMO Market Analysis
4.2.1 ROW Healthcare CMO Market by Value
5. CDMO Regional Analysis
5.1 The US Pharmaceutical CDMO Market: An Analysis
5.1.1 The US Pharmaceutical CDMO Market by Value
5.2 Europe Pharmaceutical CDMO Market: An Analysis
5.2.1 Europe Pharmaceutical CDMO Market by Value
5.3 India Pharmaceutical CDMO Market: An Analysis
5.3.1 India Pharmaceutical CDMO Market by Value
5.4 China Pharmaceutical CDMO Market: An Analysis
5.4.1 China Pharmaceutical CDMO Market by Value
6. Impact of Covid-19
6.1 Surge in Contracts to CDMOs
6.2 Supply Chain Issues amidst Surge in Demand for CDMOs
6.3 Preparedness Measures in the Event of Supply Chain Disruption
7. Market Dynamics
7.1 Growth Drivers
7.1.1 Surging Geriatric Population
7.1.2 Rising Healthcare Expenditure
7.1.3 Increasing Spread Chronic Diseases
7.1.4 Escalating Demand for Generic Drugs
7.2 Challenges
7.2.1 Rapid Technological Advancement
7.2.2 Dependent on Patents, Copyrights, Trademarks and Trade Secrets
7.3 Market Trends
7.3.1 Escalating Role of Artificial Intelligence Technology
7.3.2 Evolution of Advanced Respiratory Equipment
8. Competitive Landscape
8.1 Global Healthcare CMO Market Players Financial Comparison
9. Company Profiles
9.1 Catalent, Inc.
9.1.1 Business Overview
9.1.2 Financial Overview
9.1.3 Business Strategy
9.2 Recipharm
9.2.1 Business Overview
9.2.2 Financial Overview
9.2.3 Business Strategy
9.3 Aurobindo Pharma Limited
9.3.1 Business Overview
9.3.2 Financial Overview
9.3.3 Business Strategy
9.4 Boehringher Ingelheim
9.4.1 Business Overview
9.4.2 Financial Overview
9.4.3 Business Strategy
List of Figures
Figure 1: Healthcare CMOs Market Segments
Figure 2: Pharmaceutical Outsourcing Market Segments
Figure 3: Value Chain of a Drug
Figure 4: Global Healthcare CMO Market by Value; 2018-2020 (US$ Billion)
Figure 5: Global Healthcare CMO Market by Value; 2021-2025 (US$ Billion)
Figure 6: Global Healthcare CMO Market by Segments; 2020 (Percentage, %)
Figure 7: Global Medical Device CMO Market by Value; 2018-2020 (US$ Billion)
Figure 8: Global Medical Device CMO Market by Value; 2021-2025 (US$ Billion)
Figure 9: Global Pharmaceutical CMO Market by Value; 2018-2020 (US$ Billion)
Figure 10: Global Pharmaceutical CMO Market by Value; 2021-2025 (US$ Billion)
Figure 11: Global Pharmaceutical CMO Market by Segments; 2020 (Percentage, %)
Figure 12: Global Active Pharmaceutical Ingredient CMO Market by Value; 2018-2020 (US$ Billion)
Figure 13: Global Active Pharmaceutical Ingredient CMO Market by Value; 2021-2025 (US$ Billion)
Figure 14: Global Others Pharmaceutical CMO Market by Value; 2018-2020 (US$ Billion)
Figure 15: Global Others Pharmaceutical CMO Market by Value; 2021-2025 (US$ Billion)
Figure 16: Global Healthcare CMO Market by Region; 2020 (Percentage, %)
Figure 17: Global Pharmaceutical CDMO Market by Value; 2020-2025 (US$ Billion)
Figure 18: Global Pharmaceutical CDMO Market by Region; 2020 (Percentage, %)
Figure 19: Asia Pacific Healthcare CMO Market by Value; 2018-2020 (US$ Billion)
Figure 20: Asia Pacific Healthcare CMO Market by Value; 2021-2025 (US$ Billion)
Figure 21: ROW Healthcare CMO Market by Value; 2018-2020 (US$ Billion)
Figure 22: ROW Healthcare CMO Market by Value; 2021-2025 (US$ Billion)
Figure 23: The US Pharmaceutical CDMO Market by Value; 2020-2025 (US$ Billion)
Figure 24: Europe Pharmaceutical CDMO Market by Value; 2020-2025 (US$ Billion)
Figure 25: India Pharmaceutical CDMO Market by Value; 2020-2025 (US$ Billion)
Figure 26: China Pharmaceutical CDMO Market by Value; 2020-2025 (US$ Billion)
Figure 27: Global Population Proportion above 65 Years of Age; 2019-2030 (Million)
Figure 28: Global Healthcare Expenditure; 2017-2022 (US$ Trillion)
Figure 29: Global Chronic Disease Growth; 2016-2025 (Percentage, %)
Figure 30: Global Generic Drugs Market Value, 2020-2025 (US$ Billion)
Figure 31: Global Healthcare Artificial Intelligence Market Value; 2020-2025 (US$ Billion)
Figure 32: Catalent Net Revenue; 2016-2020 (US$ Billion)
Figure 33: Catalent, Inc. Net Revenue by Segments; 2020 (Percentage, %)
Figure 34: Catalent, Inc. Net Revenue by Region; 2020 (Percentage, %)
Figure 35: Recipharm Net Sales; 2016-2020 (US$ Billion)
Figure 36: Recipharm Net Sales by Segments; 2020 (Percentage, %)
Figure 37: Recipharm Net Sales by Region; 2020 (Percentage, %)
Figure 38: Aurobindo Revenue; 2017-2021 (US$ Billion)
Figure 39: Aurobindo Revenue by Segments; 2021 (Percentage, %)
Figure 40: Aurobindo Revenue by Region; 2021 (Percentage, %)
Figure 41: Boehringher Ingelheim Net Sales; 2016-2020 (US$ Billion)
Figure 42: Boehringher Ingelheim Net Sales by Segments; 2020 (Percentage, %)
Figure 43: Boehringher Ingelheim Net Sales by Geography; 2020 (Percentage, %)
Table 1: Contracts Placed with Pharmaceutical CDMOs; 2020
Table 2: Global Healthcare CMO Market Players Financial Comparison; 2020/2021
